CCL2 and cancer: In addition, pharmacological inhibition of CCL2/CCR4/Vav2/Rac1/MLC signaling pathway can effectively reduce the motility of cancer cells, thereby inhibiting local invasion and distant lymph node metastasis in head and neck squamous cell carcinoma (HNSCC) cells (33).